Atherosclerosis

Article	Citations
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications	215
Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study	98
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force	89
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene	86
APOE gene variants in primary dyslipidemia	78
Carotid intima-media thickness should not be referred to as subclinical atherosclerosis: A recommended update to the editorial policy at Atherosclerosis	75
Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway	75
EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, cross	74
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective	68
Trends in lipid-modifying agent use in 83 countries	68
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?	64
Epicardial fat and coronary artery disease: Role of cardiac imaging	62
Non-genetic influences on lipoprotein(a) concentrations	59
Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors	58
The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis	56
Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial	53
Transendothelial transport of lipoproteins	53
Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic	51
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK	51
Shift work, and particularly permanent night shifts, promote dyslipidaemia: A systematic review and meta-analysis	51
Lipoprotein(a) and ethnicities	48
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?	48
HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis	48
Existing and emerging strategies to lower Lipoprotein(a)	47
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study	47

Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule	46
South Asian ethnicity as a risk factor for coronary heart disease	45
Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient	45
Lipoprotein (a) and diabetes mellitus	44
Marked plaque regression in homozygous familial hypercholesterolemia	42
Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis	42
The multifaceted impact of complement on atherosclerosis	42
Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies	42
Lipoprotein(a): An underestimated inflammatory mastermind	41
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium	41
Multifaceted role of extracellular vesicles in atherosclerosis	39
Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study	39
Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology	39
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis	38
Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort	38
Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets	37
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society	37
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease	37
Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease	37
Is protein the forgotten ingredient: Effects of higher compared to lower protein diets on cardiometabolic risk factors. A systematic review and meta-analysis of randomised controlled trials	36
Recent advances in demystifying the metabolism of lipoprotein(a)	36
Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications	36
Coronavirus disease-19: The multi-level, multi-faceted vasculopathy	35
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study	35
Physical activity and exercise improve retinal microvascular health as a biomarker of cardiovascular risk: A systematic review	35
Effects of resistance training on endothelial function: A systematic review and meta-analysis	35
Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis	34
Ischemia and no obstructive coronary arteries (INOCA): A narrative review	33
Targeting the chemokine network in atherosclerosis	33
Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography	32
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects	32
Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives	31
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy	30
Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia	30
Fetal toxicity associated with statins: A systematic review and meta-analysis	30
Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease	30
Lifestyle intervention using mobile technology and smart devices in patients with high cardiovascular risk: A pragmatic randomised clinical trial	30
Sex differences in lipids: A life course approach	30
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study	30
Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects	29
Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis	29
Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis	29
Vascular imaging of atherosclerosis: Strengths and weaknesses	29
Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease	28
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study	28
International Union of Angiology (IUA) consensus paper on imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced approaches	28
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry	28
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19	28
Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion	28
Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis	27

The emerging landscape of peptide-based inhibitors of PCSK9	27
A systematic review and meta-analysis on the effects of statins on pregnancy outcomes	27
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes	27
Fasting plasma glucose and subsequent cardiovascular disease among young adults: Analysis of a nationwide epidemiological database	27
Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study	27
Targeting the phenotypic switch of vascular smooth muscle cells to tackle atherosclerosis	26
Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes	26
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features	26
Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study	26
Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women	25
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment	25
Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care	25
Role of mitochondrial DNA copy number in incident cardiovascular diseases and the association between cardiovascular disease and type 2 diabetes: A follow-up study on middle-aged women	25
Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe mice	25
The multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular events	24
Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis	24
Associations between plasma ceramides and mortality in patients with coronary artery disease	24
Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study	24
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook	24
Chronic kidney disease measures for cardiovascular risk prediction	23
The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease	23
Cumulative dyslipidemia with arterial stiffness and carotid IMT progression in asymptomatic adolescents: A simulated intervention longitudinal study using temporal inverse allocation model	23
Sex differences in impact of long-term burden and trends of body mass index and blood pressure from childhood to adulthood on arterial stiffness in adults: A 30-year cohort study	23
Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records	23
Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function	23
IMT is not atherosclerosis	23
Actin remodelling of the endothelium during transendothelial migration of leukocytes	22
Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study	22
Statin therapy for the primary prevention of cardiovascular disease: Pros	22
Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages	22
Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data	22
Characteristics of atherosclerosis in femoropopliteal artery and its clinical relevance	22
Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry Ⅲ	22
Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study	22
Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy	22
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target	22
Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome	22
Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?	22
Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial	22
Mendelian Randomization: Principles and its usage in Lp(a) research	21
Lipoprotein (a) and aortic valve calcium in South Asians compared to other race/ethnic groups	21
Cardiovascular effects of omega-3 fatty acids: Hope or hype?	21
Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses	21
Does variation in serum LDL-cholesterol response to dietary fatty acids help explain the controversy over fat quality and cardiovascular disease risk?	21
Single cell analyses to understand the immune continuum in atherosclerosis	20
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study	20
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis	20
Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen	20
A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia	20
Lipid-lowering therapies: Better together	20
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study	20
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function	19
Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies	19
Genotype-phenotype correlation in pseudoxanthoma elasticum	19
DA VINCI study: Change in approach to cholesterol management will be needed to reduce the implementation gap between guidelines and clinical practice in Europe	19
Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries	19
Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort	19
Smoking and sex differences in first manifestation of cardiovascular disease	19
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTe	19
Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study	19
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia	19
Possible association between eating behaviors and cardiovascular disease in the general population: Analysis of a nationwide epidemiological database	19
Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling	19
Relationship between muscle mass index and LDL cholesterol target levels: Analysis of two studies of the Korean population	19
Is estimated cardiorespiratory fitness an effective predictor for cardiovascular and all-cause mortality? A meta-analysis	19
Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohort	19
Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve	19
Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits	18
Estimation of the major cardiovascular events prevention with Inclisiran	18
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–2020	18
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity	18
PCSK9 promotes arterial medial calcification	18
The association of serum lipid and lipoprotein levels with total and differential leukocyte counts: Results of a cross-sectional and longitudinal analysis of the UK Biobank	18
Normalized wall index, intraplaque hemorrhage and ulceration of carotid plaques correlate with the severity of ischemic stroke	18
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque	18
High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy	18
Association of circulating branched-chain amino acids with risk of cardiovascular disease: A systematic review and meta-analysis	18
Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice	17
Saline-induced coronary hyperemia with continuous intracoronary thermodilution is mediated by intravascular hemolysis	17
LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis	17

Exercise-induced endothelial Mecp2 lactylation suppresses atherosclerosis via the Ereg/MAPK signalling pathway	17
Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA)	17
Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions	17
Sex differences in the genetic and molecular mechanisms of coronary artery disease	17
Atherosclerosis risk classification with computed tomography angiography: A radiologic-pathologic validation study	17
The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis	16
The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease	16
Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021	16
Carotid stent occlusion after emergent stenting in acute ischemic stroke: Incidence, predictors and clinical relevance	16
A phase 2 trial of the efficacy and safety of evinacumab in patients with severe hypertriglyceridemia	16
An elevated ankle-brachial index is not a valid proxy for peripheral medial arterial calcification	16
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia	16
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification	16
Sex differences in vascular endothelial cells	16
The C57Bl/6J mouse strain is more susceptible to angiotensin II-induced aortic aneurysm formation than C57Bl/6N	16
Risk of peripheral artery disease according to race and sex: The Atherosclerosis Risk in Communities (ARIC) study	16
Lipolytic enzymes and free fatty acids at the endothelial interface	16
Spousal similarities in cardiometabolic risk factors: A cross-sectional comparison between Dutch and Japanese data from two large biobank studies	16
Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study	15
Periodontal treatment and vascular inflammation in patients with advanced peripheral arterial disease: A randomized controlled trial	15
Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: The Atherosclerosis Risk in Communities (ARIC) study	15
Predicted impact of increasing average ambient temperature over the coming century on mortality from cardiovascular disease and stroke in the USA	15
The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease	15
Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)	15
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells	15
Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation	15
Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality	15
Nrf2 deficiency attenuates atherosclerosis by reducing LOX-1-mediated proliferation and migration of vascular smooth muscle cells	15
How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?	15
Impact of NAFLD and its pharmacotherapy on lipid profile and CVD	15
Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome	15
Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis	15
Low shear stress inhibits endothelial mitophagy via caveolin-1/miR-7-5p/SQSTM1 signaling pathway	15
TIGAR mitigates atherosclerosis by promoting cholesterol efflux from macrophages	15
Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system	15
Endothelial cells exposed to atheroprotective flow secrete follistatin-like 1 protein which reduces transcytosis and inflammation	15
Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study	15
Familial hypercholesterolemia and cardiovascular disease in older individuals	15
Abdominal aortic calcification is associated with a higher risk of injurious fall-related hospitalizations in older Australian women	15
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update	14
A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: A series of cases	14
Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study	14
Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals	14
Pulse wave velocity, augmentation index, and carotid intima-media thickness are each associated with different inflammatory protein signatures in young healthy adults: The lifestyle, biomarkers and at	14
miR-30b-5p releases HMGB1 via UBE2D2/KAT2B/HMGB1 pathway to promote pro-inflammatory polarization and recruitment of macrophages	14
Macrophage metabolic regulation in atherosclerotic plaque	14
Circulatory markers of immunity and carotid atherosclerotic plaque	14
Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis	14
Debris collected in-situ from spontaneously ruptured atherosclerotic plaque invariably contains large cholesterol crystals and evidence of activation of innate inflammation: Insights from non-obstruct	14
Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention	14
The association between markers of inflammation and retinal microvascular parameters: A systematic review and meta-analysis	13
Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from	13
The relationship between serum levels of LOX-1 ligand containing ApoAI as a novel marker of dysfunctional HDL and coronary artery calcification in middle-aged Japanese men	13
New prediction tools and treatment for ACS patients with plaque erosion	13
Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population	13
Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a)	13
Longitudinal effects of smoking cessation on carotid artery atherosclerosis in contemporary smokers: The Wisconsin Smokers Health Study	13
Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study	13
Serum calcium and long-term outcome after ischemic stroke: Results from the China National stroke registry III	13
Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial	13
Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center–based Prospective Study	13
De novo DNA methylation induced by circulating extracellular vesicles from acute coronary syndrome patients	13
Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease	13
Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows	13
Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study	13
CREB/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia	13
The emerging landscape of non-conventional RNA functions in atherosclerosis	13
Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism	13
High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA	13
Regulation of intestinal LDLR by the LXR-IDOL axis	13
Lifetime risk predictions for cardiovascular diseases: Competing risks analyses on a population-based cohort in Sweden	13
Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study	12
Pre-infection HDL-cholesterol levels and mortality among elderly patients infected with SARS-CoV-2	12
Statin initiation and all-cause mortality in incident statin-naïve dialysis patients	12
Systematic review of genome-wide association studies of abdominal aortic aneurysm	12
LDLR variants functional characterization: Contribution to variant classification	12
Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by increasing tetrahydrobiopterin via regulation of GTP-cyclohydrolase 1 and reducing uncoupled endothelial nitric oxide synthase activity	12
Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population	12
Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging	12
Meta-analysis of randomized clinical trials comparing PCSK9 monoclonal antibody versus ezetimibe/placebo in patients at high cardiovascular risk	12
Arterial stiffness but not carotid intima-media thickness progression precedes premature structural and functional cardiac damage in youth: A 7-year temporal and mediation longitudinal study	12
Joint exposure to positive affect, life satisfaction, broad depression, and neuroticism and risk of cardiovascular diseases: A prospective cohort study	12
Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases	12
Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status	12
Protective lifestyle behaviours and lipoprotein particle subclass profiles in a middle-to older-aged population	12
Associations between body mass index trajectories in childhood and cardiovascular risk factors in adulthood	12
Association of epicardial adipose tissue with coronary CT angiography plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus	12
Effect of biological sex on human circulating lipidome: An overview of the literature	12
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis	12
CD34+ progenitors are predictive of mortality and are associated with physical activity in cardiovascular disease patients	12
Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients	12
Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR	12
Inhibition of extracellular matrix integrity attenuates the early phase of aortic medial calcification in a rodent model	12
Diabetes, its duration, and the long-term risk of abdominal aortic aneurysm: The Atherosclerosis Risk in Communities (ARIC) Study	12
Atherogenic lipidomics profile in healthy individuals with low cardiorespiratory fitness: The HUNT3 fitness study	12